Compare · LFST vs OPCH
LFST vs OPCH
Side-by-side comparison of LifeStance Health Group Inc. (LFST) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFST and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.23B, about 1.1x LFST ($3.01B).
- Over the past year, LFST is up 26.1% and OPCH is down 35.2% - LFST leads by 61.3 points.
- OPCH has been more active in the news (12 items in the past 4 weeks vs 6 for LFST).
- LFST has more recent analyst coverage (16 ratings vs 14 for OPCH).
- Company
- LifeStance Health Group Inc.
- Option Care Health Inc.
- Price
- $7.50-3.35%
- $20.52-0.22%
- Market cap
- $3.01B
- $3.23B
- 1M return
- +3.23%
- -2.93%
- 1Y return
- +26.05%
- -35.23%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 6
- 12
- Recent ratings
- 16
- 14
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest LFST
- Director Shuey Eric sold $1,951,763 worth of shares (243,362 units at $8.02) (SEC Form 4)
- Director Black Darren M. sold $47,315,281 worth of shares (5,899,661 units at $8.02) (SEC Form 4)
- Director Bessler Robert sold $4,611,773 worth of shares (575,034 units at $8.02) (SEC Form 4)
- Large owner Tpg Gp A, Llc sold $226,821,183 worth of shares (28,281,943 units at $8.02) (SEC Form 4)
- SEC Form 8-K filed by LifeStance Health Group Inc.
- Director Bessler Robert sold $641,250 worth of shares (75,000 units at $8.55) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.
- SEC Form 424B7 filed by LifeStance Health Group Inc.
- LifeStance Health Group Announces Pricing of Secondary Public Offering
- LifeStance Health Group Announces Launch of Secondary Public Offering
Latest OPCH
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)
- Director Brandt Eric was granted 11,640 shares, increasing direct ownership by 112% to 21,999 units (SEC Form 4)
- Option Care Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits